vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and FIRSTSUN CAPITAL BANCORP (FSUN). Click either name above to swap in a different company.
FIRSTSUN CAPITAL BANCORP is the larger business by last-quarter revenue ($110.0M vs $62.1M, roughly 1.8× Cytek Biosciences, Inc.). FIRSTSUN CAPITAL BANCORP runs the higher net margin — 19.6% vs -70.9%, a 90.6% gap on every dollar of revenue. Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 6.9%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
FirstSun Capital Bancorp is a U.S.-headquartered financial holding company that offers a comprehensive range of banking and financial services, including commercial and consumer lending, deposit products, wealth management, and treasury solutions. It mainly serves individual customers, small and medium-sized enterprises, and corporate clients across U.S. regional markets.
CTKB vs FSUN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $110.0M |
| Net Profit | $-44.1M | $21.6M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | — |
| Net Margin | -70.9% | 19.6% |
| Revenue YoY | 8.1% | — |
| Net Profit YoY | -557.1% | -8.4% |
| EPS (diluted) | — | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $110.0M | ||
| Q4 25 | $62.1M | $110.2M | ||
| Q3 25 | $52.3M | $107.3M | ||
| Q2 25 | $45.6M | $105.6M | ||
| Q1 25 | $41.5M | $96.2M | ||
| Q4 24 | $57.5M | $98.7M | ||
| Q3 24 | $51.5M | $98.2M | ||
| Q2 24 | $46.6M | $96.2M |
| Q1 26 | — | $21.6M | ||
| Q4 25 | $-44.1M | $24.8M | ||
| Q3 25 | $-5.5M | $23.2M | ||
| Q2 25 | $-5.6M | $26.4M | ||
| Q1 25 | $-11.4M | $23.6M | ||
| Q4 24 | $9.6M | $16.4M | ||
| Q3 24 | $941.0K | $22.4M | ||
| Q2 24 | $-10.4M | $24.6M |
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | -9.0% | 29.0% | ||
| Q3 25 | -17.6% | 26.4% | ||
| Q2 25 | -23.3% | 31.2% | ||
| Q1 25 | -36.1% | 30.9% | ||
| Q4 24 | 5.2% | 20.4% | ||
| Q3 24 | -8.2% | 29.1% | ||
| Q2 24 | -18.3% | 32.3% |
| Q1 26 | — | 19.6% | ||
| Q4 25 | -70.9% | 22.5% | ||
| Q3 25 | -10.5% | 21.6% | ||
| Q2 25 | -12.2% | 25.0% | ||
| Q1 25 | -27.5% | 24.5% | ||
| Q4 24 | 16.8% | 16.6% | ||
| Q3 24 | 1.8% | 22.8% | ||
| Q2 24 | -22.4% | 25.5% |
| Q1 26 | — | $0.76 | ||
| Q4 25 | — | $0.89 | ||
| Q3 25 | — | $0.82 | ||
| Q2 25 | — | $0.93 | ||
| Q1 25 | — | $0.83 | ||
| Q4 24 | — | $0.57 | ||
| Q3 24 | — | $0.79 | ||
| Q2 24 | — | $0.88 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $413.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $1.2B |
| Total Assets | $461.5M | $8.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $413.7M | ||
| Q4 25 | $90.9M | $652.6M | ||
| Q3 25 | $93.3M | $659.9M | ||
| Q2 25 | $75.5M | $785.1M | ||
| Q1 25 | $95.3M | $621.4M | ||
| Q4 24 | $98.7M | $615.9M | ||
| Q3 24 | $162.3M | $573.7M | ||
| Q2 24 | $177.9M | $535.8M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $341.7M | $1.2B | ||
| Q3 25 | $378.6M | $1.1B | ||
| Q2 25 | $377.6M | $1.1B | ||
| Q1 25 | $379.6M | $1.1B | ||
| Q4 24 | $395.7M | $1.0B | ||
| Q3 24 | $385.5M | $1.0B | ||
| Q2 24 | $389.1M | $996.6M |
| Q1 26 | — | $8.6B | ||
| Q4 25 | $461.5M | $8.5B | ||
| Q3 25 | $494.9M | $8.5B | ||
| Q2 25 | $493.3M | $8.4B | ||
| Q1 25 | $482.6M | $8.2B | ||
| Q4 24 | $499.5M | $8.1B | ||
| Q3 24 | $491.2M | $8.1B | ||
| Q2 24 | $483.7M | $8.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | — |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $111.5M | ||
| Q3 25 | $-3.9M | $49.4M | ||
| Q2 25 | $108.0K | $15.0M | ||
| Q1 25 | $-125.0K | $26.4M | ||
| Q4 24 | $2.0M | $101.1M | ||
| Q3 24 | $13.2M | $48.1M | ||
| Q2 24 | $6.2M | $20.9M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | $104.0M | ||
| Q3 25 | $-4.6M | $47.6M | ||
| Q2 25 | $-1.5M | $13.0M | ||
| Q1 25 | $-974.0K | $24.3M | ||
| Q4 24 | $1.1M | $95.7M | ||
| Q3 24 | $12.2M | $47.1M | ||
| Q2 24 | $5.2M | $19.9M |
| Q1 26 | — | — | ||
| Q4 25 | -2.9% | 94.3% | ||
| Q3 25 | -8.7% | 44.4% | ||
| Q2 25 | -3.2% | 12.3% | ||
| Q1 25 | -2.3% | 25.3% | ||
| Q4 24 | 1.9% | 97.0% | ||
| Q3 24 | 23.7% | 47.9% | ||
| Q2 24 | 11.0% | 20.6% |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 6.8% | ||
| Q3 25 | 1.3% | 1.6% | ||
| Q2 25 | 3.5% | 1.9% | ||
| Q1 25 | 2.0% | 2.1% | ||
| Q4 24 | 1.6% | 5.5% | ||
| Q3 24 | 2.0% | 1.1% | ||
| Q2 24 | 2.3% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.49× | ||
| Q3 25 | — | 2.13× | ||
| Q2 25 | — | 0.57× | ||
| Q1 25 | — | 1.12× | ||
| Q4 24 | 0.21× | 6.18× | ||
| Q3 24 | 14.05× | 2.15× | ||
| Q2 24 | — | 0.85× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
FSUN
| Net Interest Income | $82.8M | 75% |
| Noninterest Income | $27.2M | 25% |
